1. Cortes, Jose R, Filip, Ioan, Albero, Robert, Rabadan, Raul, Palomero, Teresa. . Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma. In Cell reports, 39, 110695. doi:10.1016/j.celrep.2022.110695. https://pubmed.ncbi.nlm.nih.gov/35443168/
2. Zhong, Weiming, Xiong, Kaifen, Li, Shuwang, Li, Chuntao. . Macrophage polarization-related gene signature for risk stratification and prognosis of survival in gliomas. In Journal of cellular and molecular medicine, 28, e70000. doi:10.1111/jcmm.70000. https://pubmed.ncbi.nlm.nih.gov/39448550/
3. Navinés-Ferrer, Arnau, Ainsua-Enrich, Erola, Serrano-Candelas, Eva, Olivera, Ana, Martin, Margarita. 2021. MYO1F Regulates IgE and MRGPRX2-Dependent Mast Cell Exocytosis. In Journal of immunology (Baltimore, Md. : 1950), 206, 2277-2289. doi:10.4049/jimmunol.2001211. https://pubmed.ncbi.nlm.nih.gov/33941653/
4. Taki, Tomohiko, Akiyama, Masaharu, Saito, Shinobu, Eto, Yoshikatsu, Hayashi, Yasuhide. . The MYO1F, unconventional myosin type 1F, gene is fused to MLL in infant acute monocytic leukemia with a complex translocation involving chromosomes 7, 11, 19 and 22. In Oncogene, 24, 5191-7. doi:. https://pubmed.ncbi.nlm.nih.gov/15897884/
5. Morrish, Emma, Wartewig, Tim, Kratzert, Andreas, Steiger, Katja, Ruland, Jürgen. 2023. The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice. In European journal of immunology, 53, e2250147. doi:10.1002/eji.202250147. https://pubmed.ncbi.nlm.nih.gov/36541400/
6. Wang, Heping, Cui, Zhihui, Sun, Wanwei, He, Ruirui, Wang, Chenhui. 2024. MYO1F positions cGAS on the plasma membrane to ensure full and functional signaling. In Molecular cell, 85, 150-165.e7. doi:10.1016/j.molcel.2024.11.026. https://pubmed.ncbi.nlm.nih.gov/39694035/
智鼠故事 
